Other conditions decisions — 2022

The Veteran's claims of entitlement to service connection for joint pain, muscle pain, a sleep disorder, and a stomach disorder have been granted.,These conditions were previously denied due to lack of evidence linking them to service or an undiagnosed illness.

The Veteran withdrew her appeal for service connection of a left leg disorder, and the Board dismissed the case.

The Veteran's TDIU claim is granted as they are unable to secure and follow a substantially gainful occupation due to their service-connected arthritis.

The Board has denied service connection for blurred vision and balance problems as there is no current diagnosis of these conditions.,The Veteran's TDIU claim was also remanded to the Director of Compensation Service for extraschedular consideration.

The Board has decided to remand the case due to new information regarding the Appellant's request for an upgrade of his discharge characterization. The AOJ needs to obtain and review any pending applications or decisions related to this request.

The Board has determined that the overpayment of educational assistance benefits was not properly created due to discrepancies in returned payments and reissued checks. The Veteran's address changes were not accurately reflected, leading to potential errors in payment distribution.

The Board has remanded the case due to insufficient medical opinion regarding whether the Veteran's cause of death was related to his military service, specifically Agent Orange exposure.

The Board denied the Veteran's claim for service connection for a growth on his back of the neck, finding that it is not related to his service.

The Veteran's claims for a higher disability rating in excess of 60 percent and an earlier effective date prior to May 13, 2013, were dismissed as the Veteran did not have any pending claims at the time of his death.

The Veteran's perichondritis is remanded for a VA examination to determine if it is at least as likely as not related to service, including his in-service skin disorder.

The Veteran's squamous cell carcinoma of the tongue is found to be related to his in-service herbicide agent exposure, and service connection for this condition is granted.

The Board has decided to remand the case due to inadequate opinion from a VA examiner regarding the Veteran's neck condition, which may be related to motor vehicle accidents in 2002 and 2004.

The Board denied the Veteran's claims for service connection for hypoxemia, residuals of a cerebrovascular accident, and a cardiac condition, including myocardial infarction, coronary bypass graft, atrial fibrillation, endocarditis, and mitral valve repair. The Board found that there was no evidence linking these conditions to active duty service.

The Board has remanded the Veteran's claims for further development due to incomplete compliance with previous remands. The issues of service connection, increased rating for hypertension, and TDIU prior to January 21, 2020 are now ready for adjudication.

The Veteran's claim for compensation under 38 U.S.C. § 1151 for transverse myelitis due to a flu vaccine administered at the VA is denied as there was no evidence of carelessness, negligence, or fault on the part of VA.

The Board has decided that the Appellant's August 2016 substantive appeal for service connection for the cause of the Veteran's death was untimely. The case is being remanded to allow her to provide medical records from when she claims she could not file her appeal due to illness.

The Board granted service connection for monoclonal gammopathy of undetermined significance (MGUS) due to herbicide agent exposure under the PACT Act, effective from the date of the decision.

The Veteran's colon cancer was not present during service and is not linked to any service-connected condition or presumed exposure. The Board denied service connection for the condition.

Your appeal has been dismissed due to the Veteran's death. The Board does not have jurisdiction to decide your claims now.

The Veteran's service-connected right leg varicose veins are rated at 40 percent effective December 20, 2021. This rating is based on persistent edema and stasis pigmentation or eczema with intermittent ulceration.